Research

neurons
October 11, 2012

VU scientists cheer Nobel Prize for stem cell research

Vanderbilt University scientists are cheering this year’s Nobel Prize in Medicine for recognizing the discovery that mature cells can be “reprogrammed” into other cell types — a finding which they said has electrified their work.

By Bill Snyder
October 4, 2012

Proteins help flip tumor’s invasive switch

Vanderbilt investigators have identified how two key components of cancer’s invasive “switch” — the series of signaling events that turn on a tumor cell’s invasive behavior — work together.

By Leigh MacMillan
September 19, 2012

How ‘Jedi’ disposes of dead neurons

The protein Syk is essential for clearing away neuron “corpses” in the developing peripheral nervous system.

By Leigh MacMillan
insurance card
September 13, 2012

Study tracks potential coverage gaps under Affordable Care Act

An analysis of Massachusetts’ health care reform program by a Vanderbilt researcher indicates insurance gaps may remain as the Affordable Care Act (ACA) expands insurance coverage beginning in 2014.

By VUMC News and Communications
Joan Steitz (Yale University)
September 10, 2012

Yale University’s Joan Steitz awarded 2012 Vanderbilt Prize

By Bill Snyder
August 28, 2012

Clues to retinal cell degeneration

A reversible chemical modification of rhodopsin, a receptor for light, plays a role in the degeneration of retinal cells.

By Leigh MacMillan
August 24, 2012

Tool helps plumb electronic records

A tool developed for one institution’s electronic health records can work at other institutions, potentially facilitating the use of these records in research studies.
By VUMC News and Communications
August 14, 2012

Flu Tool guides patient decision-making

Studies of Flu Tool, a computer application that guides health care decision-making, suggests that patients are willing to use these types of resources.
By Leigh MacMillan
August 9, 2012

New therapeutic target for cold, flu viruses identified

Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs. Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells.
By Leigh MacMillan
July 17, 2012

Insights for neuroscience drug discovery

When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.
By Leigh MacMillan
May 15, 2012

New clue to ADHD

A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.
By Bill Snyder
May 11, 2012

Perfect timing for sensory processing

Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.
By VUMC News and Communications
May 10, 2012

Probing epilepsy’s molecular sparks

Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.
By Leigh MacMillan
1 … 122 123 124 125 126 … 135